ECMO for the pregnant and peripartum patient: A practical review of indications, unique management considerations, and an approach framework

Carmen S. Hrymak*, Ahmed Labib, Bindu Akkanti, Marta V. Antonini, Bradley Bruggeman, Matthew J. Griffee, Silver Heinsar, Jeffrey P. Jacobs, Michelle Larzelere, Emily Naoum, Erika O’Neil, Dikea Roussos-Ross, Akram M. Zaaqoq, Giles J. Peek, Rakesh C. Arora

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations

Abstract

The use of extracorporeal membrane oxygenation (ECMO) to support the pregnant patient and fetus requires a complex decision-making process. Peripartum ECMO requires coordinated and informed decision-making between an interdisciplinary team of experts, incorporating the unique considerations and, at times, competing physiologic priorities of the pregnant patient. It is often confounded by a scarcity of local relevant experience engendered by its rare occurrence. No event has made the need for an organized approach to the utilization of ECMO in pregnant patients more pressing than the COVID pandemic. The conditions affecting pregnant patients that warrant ECMO consideration are high stakes and, at times, ethically challenging, although outcomes are favourable compared to the general population. This review provides background information and context, followed by a practical approach to the care and specific medical management of patients who are facing life-threatening conditions warranting ECMO while pregnant.

Original languageEnglish
Pages (from-to)1727-1742
Number of pages16
JournalPerfusion (United Kingdom)
Volume40
Issue number8
DOIs
StatePublished - Nov 2025

Keywords

  • amniotic fluid embolism
  • ARDS
  • cardiogenic shock
  • COVID-19
  • ECMO
  • fetal
  • fetal heart rate
  • maternal
  • pre-eclampsia
  • pregnancy/pregnant
  • pulmonary embolism
  • right ventricular failure

Cite this